| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
- Language: English
- [Nat Commun] 2021 Oct 27; Vol. 12 (1), pp. 6201. <i>Date of Electronic Publication: </i>2021 Oct 27.
- MeSH Terms: Caloric Restriction / *methods ; Lung Neoplasms / *prevention & control ; Mammary Neoplasms, Experimental / *diet therapy ; Animals ; Cell Line, Tumor ; Fasting ; Female ; Lung Neoplasms / secondary ; Mammary Neoplasms, Experimental / immunology ; Mammary Neoplasms, Experimental / pathology ; Mice ; Tumor Burden ; Tumor Microenvironment / immunology
- References: Ingram, D. K. & de Cabo, R. Calorie restriction in rodents: caveats to consider. Ageing Res. Rev. 39, 15–28 (2017). (PMID: 28610949556567910.1016/j.arr.2017.05.008) ; Di Francesco, A., Di Germanio, C., Bernier, M. & de Cabo, R. A time to fast. Science 362, 770–775 (2018). (PMID: 30442801850431310.1126/science.aau2095) ; Mitchell, S. J. et al. Daily fasting improves health and survival in male mice independent of diet composition and calories. Cell Metab. 29, 221–228.e223 (2019). (PMID: 10.1016/j.cmet.2018.08.01130197301) ; Acosta-Rodríguez, V. A., de Groot, M. H., Rijo-Ferreira, F., Green, C. B. & Takahashi, J. S. Mice under caloric restriction self-impose a temporal restriction of food intake as revealed by an automated feeder system. Cell Metab. 26, 267–277. e262 (2017). (PMID: 28683292557644710.1016/j.cmet.2017.06.007) ; Lv, M., Zhu, X., Wang, H., Wang, F. & Guan, W. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. PLoS ONE 9, e115147–e115147 (2014). (PMID: 25502434426374910.1371/journal.pone.0115147) ; Levine, M. E. et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 19, 407–417 (2014). (PMID: 24606898398820410.1016/j.cmet.2014.02.006) ; Kim, E. J. et al. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res. 13, R78 (2011). (PMID: 21834963323634210.1186/bcr2927) ; Lamming, D. W. et al. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model. Oncotarget 6, 31233–31240 (2015). (PMID: 26378060474160010.18632/oncotarget.5180) ; Sundaram, S. & Yan, L. Time-restricted feeding mitigates high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice. Nutr. Res. 59, 72–79 (2018). (PMID: 3044223510.1016/j.nutres.2018.07.014) ; Lee, C. et al. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 70, 1564–1572 (2010). (PMID: 20145127283620210.1158/0008-5472.CAN-09-3228) ; Lee, C. & Longo, V. D. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 30, 3305–3316 (2011). (PMID: 2151612910.1038/onc.2011.91) ; Raffaghello, L. et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc. Natl Acad. Sci. USA 105, 8215–8220 (2008). (PMID: 18378900244881710.1073/pnas.0708100105) ; Brandhorst, S. et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 22, 86–99 (2015). (PMID: 26094889450973410.1016/j.cmet.2015.05.012) ; Di Tano, M. et al. Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nat. Commun. 11, 2332 (2020). (PMID: 32393788721442110.1038/s41467-020-16243-3) ; de Groot, S. et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat. Commun. 11, 3083 (2020). (PMID: 32576828731154710.1038/s41467-020-16138-3) ; Caffa, I. et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583, 620–624 (2020). (PMID: 32669709788194010.1038/s41586-020-2502-7) ; Di Biase, S. et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30, 136–146 (2016). (PMID: 27411588538854410.1016/j.ccell.2016.06.005) ; de Groot, S. et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 15, 652 (2015). (PMID: 26438237459505110.1186/s12885-015-1663-5) ; Brandhorst, S., Wei, M., Hwang, S., Morgan, T. E. & Longo, V. D. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp. Gerontol. 48, 1120–1128 (2013). (PMID: 23454633376288710.1016/j.exger.2013.02.016) ; De Lorenzo, M. S. et al. Caloric restriction reduces growth of mammary tumors and metastases. Carcinogenesis 32, 1381–1387 (2011). (PMID: 21665891316512310.1093/carcin/bgr107) ; Simone, B. A. et al. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model. Cell Cycle 17, 1536–1544 (2018). (PMID: 29912618613333910.1080/15384101.2018.1471314) ; Horton, J. D., Bashmakov, Y., Shimomura, I. & Shimano, H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl Acad. Sci. USA 95, 5987–5992 (1998). (PMID: 96009042757210.1073/pnas.95.11.5987) ; Nencioni, A., Caffa, I., Cortellino, S. & Longo, V. D. Fasting and cancer: molecular mechanisms and clinical application. Nat. Rev. Cancer 18, 707 (2018). (PMID: 30327499693816210.1038/s41568-018-0061-0) ; Gennari, A., Conte, P., Rosso, R., Orlandini, C. & Bruzzi, P. Survival of metastatic breast carcinoma patients over a 20‐year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104, 1742–1750 (2005). (PMID: 1614908810.1002/cncr.21359) ; Pulaski, B. A. & Ostrand-Rosenberg, S. Mouse 4T1 breast tumor model. Curr. Protoc. Immunol. 39, 20.22.21–20.22.16 (2000). (PMID: 10.1002/0471142735.im2002s39) ; Yang, L. et al. Disease progression model of 4T1 metastatic breast cancer. J. Pharmacokinet. Pharmacodyn. 47, 105–116 (2020). (PMID: 3197061510.1007/s10928-020-09673-5) ; van Diest, P. J., van der Wall, E. & Baak, J. P. Prognostic value of proliferation in invasive breast cancer: a review. J. Clin. Pathol. 57, 675–681 (2004). (PMID: 15220356177035110.1136/jcp.2003.010777) ; Olkhanud, P. B. et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res. 69, 5996–6004 (2009). (PMID: 19567680274368810.1158/0008-5472.CAN-08-4619) ; Olkhanud, P. B. et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 + T cells to T-regulatory cells. Cancer Res. 71, 3505–3515 (2011). (PMID: 21444674309670110.1158/0008-5472.CAN-10-4316) ; Bodogai, M. et al. Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells. Cancer Res. 75, 3456–3465 (2015). (PMID: 26183924455826910.1158/0008-5472.CAN-14-3077) ; Facciabene, A., Motz, G. T. & Coukos, G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 72, 2162–2171 (2012). (PMID: 22549946334284210.1158/0008-5472.CAN-11-3687) ; Joshi, N. S. et al. Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity 43, 579–590 (2015). (PMID: 26341400482661910.1016/j.immuni.2015.08.006) ; Kiniwa, Y. et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 13, 6947–6958 (2007). (PMID: 1805616910.1158/1078-0432.CCR-07-0842) ; Chaput, N. et al. Identification of CD8+ CD25+ Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58, 520–529 (2009). (PMID: 1902291710.1136/gut.2008.158824) ; Chakraborty, S. et al. Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. Sci. Rep. 7, 1–14 (2017). (PMID: 10.1038/s41598-017-01788-z) ; Montero, A. J., Diaz-Montero, C. M., Kyriakopoulos, C. E., Bronte, V. & Mandruzzato, S. Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J. Immunother. 35, 107–115 (2012). (PMID: 2230689810.1097/CJI.0b013e318242169f) ; Wang, H.-F. et al. Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro. Cancer Immunol. Immunother. 66, 355–366 (2017). (PMID: 2791537110.1007/s00262-016-1935-1) ; Bergenfelz, C., Roxå, A., Mehmeti, M., Leandersson, K. & Larsson, A.-M. Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer. Cancer Immunol. Immunother. 69, 435–448 (2020). (PMID: 31925475704414210.1007/s00262-019-02472-z) ; Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015). (PMID: 25822788447563710.1038/nature14282) ; Bailur, J. K., Gueckel, B., Derhovanessian, E. & Pawelec, G. Presence of circulating Her2-reactive CD8+T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients. Breast Cancer Res. 17, 34 (2015). (PMID: 25849846437703410.1186/s13058-015-0541-z) ; Mahmoud, S. M. et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J. Clin. Oncol. 29, 1949–1955 (2011). (PMID: 2148300210.1200/JCO.2010.30.5037) ; Gao, Q. et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25, 2586–2593 (2007). (PMID: 1757703810.1200/JCO.2006.09.4565) ; Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA 102, 18538–18543 (2005). (PMID: 16344461131174110.1073/pnas.0509182102) ; Bates, G. J. et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24, 5373–5380 (2006). (PMID: 1713563810.1200/JCO.2006.05.9584) ; Manukian, G. et al. Caloric restriction impairs regulatory T-cells within the tumor microenvironment after radiation and primes effector T-cells. Int. J. Radiat. Oncol.* Biol.* Phys.(2021). ; Toor, S. M. et al. Myeloid cells in circulation and tumor microenvironment of breast cancer patients. Cancer Immunol. Immunother. 66, 753–764 (2017). (PMID: 28283696544514210.1007/s00262-017-1977-z) ; Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208–220 (2016). (PMID: 26858199477539810.1016/j.it.2016.01.004) ; Georgoudaki, A.-M. et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 15, 2000–2011 (2016). (PMID: 2721076210.1016/j.celrep.2016.04.084) ; Kuroda, H. et al. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes. Clin. Transl. Oncol. https://doi.org/10.1007/s12094-021-02652-3 (2021). ; Oshi, M. et al. CD8 T cell score as a prognostic biomarker for triple-negative breast cancer. Int. J. Mol. Sci. 21, 6968 (2020). (PMID: 755557010.3390/ijms21186968) ; Turbitt, W. J. et al. Physical activity plus energy restriction prevents 4T1.2 mammary tumor progression, MDSC accumulation, and an immunosuppressive tumor microenvironment. Cancer Prev. Res. 12, 493–506 (2019). (PMID: 10.1158/1940-6207.CAPR-17-0233) ; Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293–1308.e1236 (2018). (PMID: 29961579634801010.1016/j.cell.2018.05.060) ; Menares, E. et al. Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells. Nat. Commun. 10, 4401 (2019). (PMID: 31562311676501410.1038/s41467-019-12319-x) ; Egelston, C. A. et al. Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients. JCI Insight 4, e130000 (2019). (PMID: 679540810.1172/jci.insight.130000) ; Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann. Oncol. 26, 259–271 (2015). (PMID: 2521454210.1093/annonc/mdu450) ; Savas, P. et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat. Rev. Clin. Oncol. 13, 228 (2016). (PMID: 2666797510.1038/nrclinonc.2015.215) ; Arroyo‐Crespo, J. J. et al. Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression. Int. J. Cancer 145, 2267–2281 (2019). (PMID: 30860605676748010.1002/ijc.32270) ; Pearson, K. J. et al. Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction. Proc. Natl Acad. Sci. USA 105, 2325–2330 (2008). (PMID: 18287083226813510.1073/pnas.0712162105) ; Lope, V. et al. Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study. Sci. Rep. 9, 1–9 (2019). (PMID: 10.1038/s41598-019-39346-4) ; Mattison, J. A. et al. Caloric restriction improves health and survival of rhesus monkeys. Nat. Commun. 8, 14063 (2017). (PMID: 28094793524758310.1038/ncomms14063) ; MacLean, P. S., Bergouignan, A., Cornier, M.-A. & Jackman, M. R. Biology’s response to dieting: the impetus for weight regain. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 301, R581–R600 (2011). (PMID: 21677272317476510.1152/ajpregu.00755.2010) ; Teong, X. T. et al. Rationale and protocol for a randomized controlled trial comparing daily calorie restriction versus intermittent fasting to improve glycaemia in individuals at increased risk of developing type 2 diabetes. Obes. Res. Clin. Pract. 14, 176–183 (2020). (PMID: 3205771610.1016/j.orcp.2020.01.005) ; Harvie, M. N. et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int. J. Obes. 35, 714–727 (2011). (PMID: 10.1038/ijo.2010.171) ; Lee, C. et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci. Transl. Med. 4, 124ra127–124ra127 (2012). (PMID: 10.1126/scitranslmed.3003293) ; Vernieri, C., Ligorio, F., Zattarin, E., Rivoltini, L. & de Braud, F. Fasting-mimicking diet plus chemotherapy in breast cancer treatment. Nat. Commun. 11, 1–4 (2020). (PMID: 10.1038/s41467-020-18194-1) ; Phoenix, K. N., Vumbaca, F., Fox, M. M., Evans, R. & Claffey, K. P. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res. Treat. 123, 333–344 (2010). (PMID: 2020449810.1007/s10549-009-0647-z) ; Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006). (PMID: 1700853110.1126/science.1129139) ; Bense, R. D. et al. Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer. J. Natl Cancer Inst. 109, https://doi.org/10.1093/jnci/djw192 (2016). ; Kado, T., Nawaz, A., Takikawa, A., Usui, I. & Tobe, K. Linkage of CD8+ T cell exhaustion with high-fat diet-induced tumourigenesis. Sci. Rep. 9, 1–8 (2019). (PMID: 10.1038/s41598-019-48678-0) ; Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 (2006). (PMID: 1643920210.1016/j.cell.2006.01.007) ; Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618–631 (2008). (PMID: 1863335510.1038/nrc2444) ; De Sanctis, F. et al. MDSCs in cancer: conceiving new prognostic and therapeutic targets. Biochim. Biophys. Acta-Rev. Cancer 1865, 35–48 (2016). (PMID: 10.1016/j.bbcan.2015.08.001) ; San Miguel, Y. et al. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. BMC Cancer 20, 1–9 (2020). (PMID: 10.1186/s12885-020-6696-8) ; Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489–495 (2011). (PMID: 2129661510.1016/S1470-2045(10)70218-7) ; Levolger, S., van den Engel, S., Ambagtsheer, G., Ijzermans, J. N. M. & de Bruin, R. W. F. Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia. Aging (Albany, NY) 10, 4213–4223 (2018). (PMID: 30591621632667310.18632/aging.101724) ; Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 1–7 (2017). (PMID: 10.1038/s41598-017-17204-5) ; Meuten, D. J., Moore, F. M. & George, J. W. Mitotic count and the field of view area:time to standardize. Vet. Pathol. 53, 7–9 (2016). (PMID: 2671281310.1177/0300985815593349) ; van Diest, P. J. et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum. Pathol. 23, 603–607 (1992). (PMID: 159238110.1016/0046-8177(92)90313-R)
- Grant Information: FI2 GM123963 United States GM NIGMS NIH HHS
- Entry Date(s): Date Created: 20211028 Date Completed: 20211203 Latest Revision: 20230207
- Update Code: 20231215
- PubMed Central ID: PMC8551193
|
